The aim of this study was to examine the dose-response relationship of inhaled budesonide
in adolescents and adults with asthma. A meta-analysis was carried out on placebo …

Objectives: The aim of this study was to examine the efficacy of budesonide administered
once daily compared to twice daily in asthma. Methodology: Meta‐analysis of randomised …

Background. Budesonide, a widely used inhaled corticosteroid (ICS) with a favorable
therapeutic ratio, is available via a dry powder inhaler (Pulmicort Turbuhaler®) and as a …

Background: The worldwide prevalence of asthma is increasing by∼ 50% per decade.
Budesonide is one of several inhaled corticosteroids available for the treatment of asthma …

Background Inhaled budesonide is a widely used inhaled corticosteroid for asthma.
Objectives The objectives of this review was to compare the efficacy of budesonide with …

BACKGROUND:: The addition of the long-acting β2-adrenergic agonist formoterol to low-to
moderate-dose budesonide has shown clinical efficacy in patients with persistent asthma …

Guidelines on the use of inhaled steroids in asthma advocate that the daily dose should be
chosen according to the severity of the disease. However, the question of the optimal …

The safety and tolerability of asthma medications are still a concern to many asthma patients
receiving long‐term treatment. Therefore, more safety data from long‐term, controlled trials …

Background Inhaled budesonide (BUD) is available in a range of doses for treating chronic
asthma. Objectives To assess the efficacy and safety of budesonide at different doses in …

Objective: To compare the effectiveness of budesonide/formoterol using fixed dosing
(BUD/FORM) with inhaled corticosteroid (ICS) alone or alternative ICS and long-acting β2 …